Microcystic adnexal carcinoma of the face treated with radiation therapy: A case report and review of the literature

被引：22

作者：

Pugh, Thomas J. ^{[1
,2
]}

Lee, Nancy Y. ^{[3
]}

Pacheco, Theresa ^{[2
,4
]}

Raben, David ^{[1
,2
]}

机构：

[1] Univ Colorado Denver, Dept Radiat Oncol, Aurora, CO USA

[2] Hlth Sci Ctr, Aurora, CO USA

[3] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA

[4] Univ Colorado Denver, Dept Radiat Oncol Dermatol, Aurora, CO USA

来源：

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2012年 / 34卷 / 07期

关键词：

microcystic adnexal carcinoma; radiation therapy; brachytherapy; skin cancer; sclerosing sweat duct carcinoma; SWEAT GLAND CARCINOMA; DUCT CARCINOMA; SERIES; SKIN; INVASION; SURGERY; TUMOR;

D O I：

10.1002/hed.21690

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Background Microcystic adnexal carcinoma is a rare, locally aggressive neoplasm most commonly occurring on the face. Minimal data are available regarding the role of radiation therapy (RT). Methods Cases treated with RT from 2 comprehensive cancer centers are reviewed along with a review of the literature. Results Three patients with microcystic adnexal carcinoma of the face were treated with curative intent. One patient received RT as monotherapy. Two patients received postoperative RT (PORT). The patient receiving RT as monotherapy experienced excellent clinical regression, had an in-field recurrence at 48-month follow-up, and is now without evidence of disease after reirradiation. Both patients receiving PORT are without evidence of disease. Conclusion PORT may improve local control in patients with microcystic adnexal carcinoma, and its use should be considered in patients with high-risk features for local recurrence. RT as monotherapy should be considered when poor cosmetic outcome can be anticipated via standard surgical treatments. (c) 2011 Wiley Periodicals, Inc. Head Neck, 2012

引用

页码：1045 / 1050

页数：6